Hydrogels are referred as natural or synthetic polymer materials that exhibit very versatile physical and biological properties. These polymers were first used as biological materials in 1960. Based on the source, the hydrogel can be obtained from natural sources or are synthetic in origin. The natural hydrogel include silk fibroin, alginate, chitosan, collagen, and hyaluronic acid. However, these natural hydrogels have few limitations such as they involve batch-to-batch variation leading to inconsistency in the product. Hence, they are often combined with synthetic hydrogels for creating a composite polymer.

Hydrogels are often used as drug delivery systems owing to its high compatibility with living tissues and property to preserve embedded proteins. Hydrogel-based drug delivery system acts as controlled drug delivery systems for delivering a certain drug such as antibiotics for a predefined duration of time. The other applications of hydrogel in medical sciences include replacement, restoration of anatomic structures, filtering wastewater, making contact lenses, and as pH sensors among others.

Market Dynamics

The growing research and development activities for using hydrogel-based drug delivery system for treating various injuries such as spinal cord injuries are contributing to the growth of hydrogel-based drug delivery system market. For instance, in January 2021, University of Arkansas biomedical engineering researcher was awarded a grant of US$100,000 from the PhRMA Foundation, an organisation that offers research grants; for developing the hydrogel-based drug delivery method for treating spinal cord injuries. The process involves embedding the stem cells in the matrix hydrogels, which facilitates better cell survival and hence can perform regenerative action for a longer duration.

 Key features of the study:

• This report provides an in-depth analysis of the global hydrogel-based drug delivery system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hydrogel-based drug delivery system market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Johnson & Johnson, Bausch & Lomb, Ocular Therapeutix, Inc, Tolmar Pharmaceuticals, Inc., Ashland, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Micropore Technologies, Neurelis, Inc., and ProLynx Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global hydrogel-based drug delivery system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global hydrogel-based drug delivery system market

Detailed Segmentation:

• Global Hydrogel-Based Drug Delivery System Market, By Source
  • Natural
    • Synthetic
    • Hybrid
• Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery
  • Oral Cavity
  • Subcutaneous
  • Topical
  • Others
• Global Hydrogel-Based Drug Delivery System Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Johnson & Johnson**
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bausch & Lomb
  • Ocular Therapeutix, Inc
  • Tolmar Pharmaceuticals, Inc.
  • Ashland
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Micropore Technologies
  • Neurelis, Inc.
  • ProLynx Inc

 “*” marked represents similar segmentation in other categories in the respective section.